查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1942518

2026年全球心臟标记检测市场报告

Cardiac Marker Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，心臟标记检测市场规模迅速扩张，预计将从2025年的71.9亿美元成长到2026年的79.3亿美元，复合年增长率达10.3%。过去几年成长要素包括高灵敏度心臟标记检测的普及程度有限、对中心检查室的依赖、心血管疾病患病率的上升、医疗专业人员意识提升以及传统的手工诊断方法。

预计未来几年，心臟标记检测市场将快速成长，到2030年市场规模将达到116.1亿美元，复合年增长率（CAGR）为10.0%。预测期内的成长要素包括：自动化和携带式心臟标记检测设备的研发、照护现场技术的日益普及、与数位健康平台的整合、人口老化和心血管风险的上升，以及试剂和试剂盒灵敏度的提高。预测期内的主要趋势包括：高灵敏度心臟生物标记检测的日益普及、就地检验设施的扩张、自动化分析仪和免疫检测系统的整合、心臟标记检测在预防心臟病学中的应用日益广泛，以及对携带式诊断设备的需求不断增长。

心血管疾病发生率的上升预计将推动未来心臟标记检测市场的扩张。心血管疾病包括影响心臟和血管的疾病，例如冠状动脉疾病、心臟衰竭和中风。心血管疾病发生率的上升与不健康的饮食、缺乏运动、吸烟、过量饮酒和空气污染密切相关。心臟标记检测透过检测心肌损伤过程中释放的生物标记物，在诊断心血管疾病、评估疾病严重程度和监测治疗效果方面发挥重要作用。例如，根据美国非营利组织美国心臟协会（American Heart Association）的数据显示，截至2024年1月，经年龄调整后的心血管疾病死亡率将达到每10万人233.3人，比前一年增加4.0%。因此，心血管疾病发生率的上升正在增强对心臟标记检测的需求。

心臟标记检测市场的主要企业正致力于开发技术先进的产品，例如心臟检测，以提供准确且具有临床应用价值的心臟健康和功能资讯。心臟检测是一种诊断测试，透过测量血液和其他检体中的特定生物标记来评估心臟功能、诊断心血管疾病并评估心臟相关风险。例如，2023年10月，中国医疗设备製造商迈瑞推出了高敏肌钙蛋白I (hs-cTnI) 和NT-proBNP心臟生物标记检测。 hs-cTnI检测展现出高灵敏度、高准确度和高可靠性，从检测极限到第99百分位基准值上限的检出率高达93%，且精密度变异係数小于5%。 NT-proBNP检测也实现了高准确度，变异係数小于5%，并最大限度地减少了常用心血管药物的影响，从而有助于心臟衰竭的准确诊断和管理。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球心臟标记检测市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 高灵敏度心臟生物标记检测的应用日益广泛
    • 扩大就地检验设施
    • 自动化分析仪和免疫检测系统的集成
    • 扩大心臟标记检测在预防心臟病学的应用
    • 对携带式诊断设备的需求不断增长

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 即时侦测设施
  • 学术研究机构
  • 心臟病诊所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球心臟标记检测市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球心臟标记检测市场规模、对比及成长率分析
  • 全球心臟标记检测市场表现：规模与成长，2020-2025年
  • 全球心臟标记检测市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 试剂、试剂盒及设备
  • 依生物标誌类型
  • 肌钙蛋白 I 和 T、肌酸激酶-MB (CK-MB)、利钠肽、肌红蛋白、高敏感性 C 反应蛋白和其他生物标记类型
  • 透过使用
  • 检测实验室、就地检验实验室、学术机构
  • 按类型细分：试剂和试剂盒
  • 肌钙蛋白检测套组、B型钠尿肽（BNP）检测套组、肌酸激酶-MB（CK-MB）检测套组、肌红蛋白检测套组及其他心臟生物标记试剂
  • 按类型细分：设备
  • 就地检验设备、自动分析仪、免疫检测系统、携带式诊断设备

第十章 区域与国家分析

  • 全球心臟标记检测市场：区域分析、预测与趋势（2020-2025年、2025-2030年预测、2035年预测）
  • 全球心臟标记检测市场：国家、市场表现及预测，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 心臟标记检测市场：竞争格局及市场占有率（2024年）
  • 心臟标记检测市场：公司估值矩阵
  • 心臟标记检测市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章：其他领先和创新企业

  • Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin SpA, PerkinElmer Inc., Meso Scale Diagnostics LLC

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年心臟标记检测市场：提供新机会的国家
  • 2030年心臟标记检测市场：新兴细分市场机会
  • 2030年心臟标记检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MCMTA04_G26Q1

Cardiac marker testing involves diagnostic tests that measure specific substances in the blood that indicate stress or damage to the heart. These markers, often proteins or enzymes, are released into the bloodstream when heart muscle is injured and are essential for diagnosing and evaluating conditions such as heart attacks, heart failure, and other cardiac diseases.

The key cardiac marker testing products include reagents, kits, and instruments. Reagents and kits are critical components in cardiac marker testing, containing the required chemicals and materials to conduct diagnostic evaluations. These tests measure biomarkers such as troponin I and T, creatine kinase-MB (CK-MB), natriuretic peptides, myoglobin, high-sensitivity C-reactive protein, and others, and are used in laboratory testing facilities, point-of-care testing sites, and academic institutions.

Tariffs are impacting the cardiac marker testing market by increasing the cost of imported reagents, kits, and diagnostic instruments. Segments such as high-sensitivity troponin test kits and automated analyzers are particularly impacted, with regions like Asia-Pacific and Europe experiencing supply chain challenges and higher operational costs. While tariffs have posed cost pressures, they also encourage local manufacturing, innovation in reagent formulations, and investment in domestic production of diagnostic instruments, thereby strengthening regional capabilities.

The cardiac marker testing market research report is one of a series of new reports from The Business Research Company that provides cardiac marker testing market statistics, including cardiac marker testing industry global market size, regional shares, competitors with a cardiac marker testing market share, detailed cardiac marker testing market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac marker testing industry. This cardiac marker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiac marker testing market size has grown rapidly in recent years. It will grow from $7.19 billion in 2025 to $7.93 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to limited availability of high-sensitivity cardiac marker tests, reliance on centralized laboratory testing, growing prevalence of cardiovascular diseases, increasing awareness among healthcare providers, conventional manual diagnostic practices.

The cardiac marker testing market size is expected to see rapid growth in the next few years. It will grow to $11.61 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to development of automated and portable cardiac marker testing devices, rising adoption of point-of-care diagnostics, integration with digital health platforms, growing geriatric population and cardiovascular risk, advancements in reagent and kit sensitivity. Major trends in the forecast period include rising adoption of high-sensitivity cardiac biomarker tests, expansion of point-of-care testing facilities, integration of automated analyzers and immunoassay systems, growing use of cardiac marker testing in preventive cardiology, increasing demand for portable diagnostic devices.

The rising incidence of cardiovascular diseases is anticipated to support the expansion of the cardiac marker testing market going forward. Cardiovascular diseases include disorders affecting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. The increasing occurrence of cardiovascular diseases is associated with unhealthy diets, physical inactivity, tobacco use, excessive alcohol consumption, and air pollution. Cardiac marker testing plays a vital role in diagnosing cardiovascular conditions, assessing disease severity, and monitoring treatment response by detecting biomarkers released during myocardial injury. For example, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000, representing a 4.0% rise compared to the previous year. As a result, the rising incidence of cardiovascular diseases is strengthening demand within the cardiac marker testing market.

Leading companies operating in the cardiac marker testing market are focusing on developing technologically advanced products, such as cardiac assays, to deliver accurate and clinically valuable insights into heart health and function. Cardiac assays are diagnostic tests that measure specific biomarkers in blood or other samples to assess cardiac function, diagnose cardiovascular diseases, and evaluate heart-related risk. For example, in October 2023, Mindray, a China-based medical device company, launched its high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarker assays. The hs-cTnI assay demonstrates high sensitivity, precision, and reliability, achieving a 93% detection rate between the limit of detection and the 99th percentile upper reference limit, with an imprecision coefficient of variation below 5%. The NT-proBNP assay delivers high precision with a coefficient of variation of <=5% while minimizing interference from common cardiovascular medications, supporting accurate heart failure diagnosis and management.

In August 2024, VION Biosciences, a US-based life sciences platform company, acquired Ansh Labs for an undisclosed amount. Through this acquisition, VION Biosciences aims to strengthen its footprint in the diagnostics sector, integrate advanced technologies, and expand its immunoassay development offerings. Ansh Labs is a US-based biotechnology company.

Major companies operating in the cardiac marker testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin S.p.A., PerkinElmer Inc., Meso Scale Diagnostics LLC, Boditech Med Inc., Response Biomedical Corp.

North America was the largest region in the cardiac marker testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac marker testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cardiac marker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac marker testing market consists of revenues earned by entities by providing services such as homocysteine testing, cardiac stress testing, genetic testing for cardiovascular risk, remote monitoring and telemedicine services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiac marker testing market also includes sales of lipoprotein(a) test kits, cardiac biomarker panels, point-of-care testing devices and related products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Marker Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses cardiac marker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiac marker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac marker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Reagents And Kits; Instruments
  • 2) By Biomarker Type: Troponin I And T; Creatine Kinase-MB (CK-MB); Natriuretic Peptide; Myoglobin; High-Sensitivity C-Reactive Protein; Other Biomarker Types
  • 3) By Application: Laboratory Testing Facilities; Point-Of-Care Testing Facilities; Academic Institutions
  • Subsegments:
  • 1) By Reagents and Kits: Troponin Test Kits; B-type Natriuretic Peptide (BNP) Test Kits; Creatine Kinase-MB (CK-MB) Test Kits; Myoglobin Test Kits; Other Cardiac Biomarker Reagents
  • 2) By Instruments: Point-Of-Care Testing Devices; Automated Analyzers; Immunoassay Systems; Portable Diagnostic Devices
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; Tosoh Corporation; Guangzhou Wondfo Biotech Co. Ltd.; Randox Laboratories Ltd.; Getein Biotech Inc.; Fujirebio Inc.; Mayo Clinic Laboratories; Alere Inc.; Nano-Ditech Corporation; Ortho Clinical Diagnostics; QuidelOrtho Corporation; DiaSorin S.p.A.; PerkinElmer Inc.; Meso Scale Diagnostics LLC; Boditech Med Inc.; Response Biomedical Corp.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Cardiac Marker Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Cardiac Marker Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Cardiac Marker Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Cardiac Marker Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of High-Sensitivity Cardiac Biomarker Tests
    • 4.2.2 Expansion Of Point-Of-Care Testing Facilities
    • 4.2.3 Integration Of Automated Analyzers And Immunoassay Systems
    • 4.2.4 Growing Use Of Cardiac Marker Testing In Preventive Cardiology
    • 4.2.5 Increasing Demand For Portable Diagnostic Devices

5. Cardiac Marker Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Point-Of-Care Testing Facilities
  • 5.4 Academic And Research Institutions
  • 5.5 Cardiology Clinics

6. Cardiac Marker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Cardiac Marker Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Cardiac Marker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Cardiac Marker Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Cardiac Marker Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Cardiac Marker Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Cardiac Marker Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Cardiac Marker Testing Market Segmentation

  • 9.1. Global Cardiac Marker Testing Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagents And Kits, Instruments
  • 9.2. Global Cardiac Marker Testing Market, Segmentation By Biomarker Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Troponin I And T, Creatine Kinase-MB (CK-MB), Natriuretic Peptide, Myoglobin, High-Sensitivity C-Reactive Protein, Other Biomarker Types
  • 9.3. Global Cardiac Marker Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions
  • 9.4. Global Cardiac Marker Testing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Troponin Test Kits, B-type Natriuretic Peptide (BNP) Test Kits, Creatine Kinase-MB (CK-MB) Test Kits, Myoglobin Test Kits, Other Cardiac Biomarker Reagents
  • 9.5. Global Cardiac Marker Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Point-Of-Care Testing Devices, Automated Analyzers, Immunoassay Systems, Portable Diagnostic Devices

10. Cardiac Marker Testing Market Regional And Country Analysis

  • 10.1. Global Cardiac Marker Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Cardiac Marker Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Cardiac Marker Testing Market

  • 11.1. Asia-Pacific Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Cardiac Marker Testing Market

  • 12.1. China Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Cardiac Marker Testing Market

  • 13.1. India Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Cardiac Marker Testing Market

  • 14.1. Japan Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Cardiac Marker Testing Market

  • 15.1. Australia Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Cardiac Marker Testing Market

  • 16.1. Indonesia Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Cardiac Marker Testing Market

  • 17.1. South Korea Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Cardiac Marker Testing Market

  • 18.1. Taiwan Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Cardiac Marker Testing Market

  • 19.1. South East Asia Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Cardiac Marker Testing Market

  • 20.1. Western Europe Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Cardiac Marker Testing Market

  • 21.1. UK Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Cardiac Marker Testing Market

  • 22.1. Germany Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Cardiac Marker Testing Market

  • 23.1. France Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Cardiac Marker Testing Market

  • 24.1. Italy Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Cardiac Marker Testing Market

  • 25.1. Spain Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Cardiac Marker Testing Market

  • 26.1. Eastern Europe Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Cardiac Marker Testing Market

  • 27.1. Russia Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Cardiac Marker Testing Market

  • 28.1. North America Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Cardiac Marker Testing Market

  • 29.1. USA Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Cardiac Marker Testing Market

  • 30.1. Canada Cardiac Marker Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Cardiac Marker Testing Market

  • 31.1. South America Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Cardiac Marker Testing Market

  • 32.1. Brazil Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Cardiac Marker Testing Market

  • 33.1. Middle East Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Cardiac Marker Testing Market

  • 34.1. Africa Cardiac Marker Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Cardiac Marker Testing Market, Segmentation By Product, Segmentation By Biomarker Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Cardiac Marker Testing Market Regulatory and Investment Landscape

36. Cardiac Marker Testing Market Competitive Landscape And Company Profiles

  • 36.1. Cardiac Marker Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Cardiac Marker Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Cardiac Marker Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Cardiac Marker Testing Market Other Major And Innovative Companies

  • Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Tosoh Corporation, Guangzhou Wondfo Biotech Co. Ltd., Randox Laboratories Ltd., Getein Biotech Inc., Fujirebio Inc., Mayo Clinic Laboratories, Alere Inc., Nano-Ditech Corporation, Ortho Clinical Diagnostics, QuidelOrtho Corporation, DiaSorin S.p.A., PerkinElmer Inc., Meso Scale Diagnostics LLC

38. Global Cardiac Marker Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Cardiac Marker Testing Market

40. Cardiac Marker Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Cardiac Marker Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Cardiac Marker Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Cardiac Marker Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer